Prof. David Denning FRCP FRCPath DCH FMedSci
Professor of Infectious Diseases in Global Health
Research Focus
Aspergillosis, global health and fungal diseases, azole resistance in Aspergillus and genetics of allergic and chronic pulmonary aspergillosis
Scientific Activities
David Denning has published more than 500 papers, books and book chapters and lectures worldwide. His writings have been cited over 45,000 times. He has successfully lead many major international collaborative science, diagnostic and treatment projects and clinical guidelines, with subsequent publication in Nature, the New England Journal of Medicine, Sience and the Lancet.
He is the Founder of 2 University spinout biotechnology companies – F2G Ltd (antifungal drug discovery and development) and Myconostica Ltd (molecular diagnostic tests for fungi), now sold to Lab21. He is Chairman of the Editorial Board of The Aspergillus Website (1998-) with over 1 million pages read per month.He has chaired the Scientific Committees of several international fungal infection meetings, and co-chairs the alternate year Advances Against Aspergillosis meetings, attracting ~400 delegates for >120 countries.
He is President of the Global Action Fund for Fungal Infections which has a mission to greatly improve outcomes from fungal infections, through greater understanding of the burden of fungal diseases, advocacy for universal access to fungal diagnostic testing and antifungal therapies, and enhancing clinical skills through education.
Significant Publications
Denning DW, Bromley MJ. How to bolster a sparse antifungal pipeline. Science 2015;347:1414-6.
Denning DW, Cadranel J, Beigelman-Aubry C, Ader, F, Chakrabarti A, Blot S, Ullman A, Dimopoulos G, Lange C, European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society. Chronic pulmonary aspergillosis – Rationale and clinical guidelines for diagnosis and management. Eur Resp J 2016; 47:45-68.
Denning DW. How the UNAIDS target of reducing annual AIDS deaths below 500,000 by 2020 can be achieved. Phil Trans Roy Soc B 2017; 371: 20150468.
Collaborators
Dr. Michael Bromley
Senior Lecturer
More about Dr. Michael Bromley...Dr. Paul Bowyer
Senior Lecturer
More about Dr. Paul Bowyer...Prof. Nick D Read
Professor of Fungal Cell Biology
More about Prof. Nick D Read...Dr. Riina Richardson DDS, PhD, FRCPath, PGCertMedEd
Senior Lecturer
More about Dr. Riina Richardson...Dr. Lily Novak Frazer
Lecturer in Medical Mycology, University of Manchester
More about Dr. Lily Novak Frazer...Dr. Desa Lilic MD MSc DSc/PhD FRCPath
Consultant and Clinical Senior Lecturer in Immunology
More about Dr. Desa Lilic...

Contact information
University Hospital of South Manchester
Southmoor Road
Manchester
M23 9LT
Email: ddenning@manchester.ac.uk
Phone: